Sara Bonstein
Chief Financial Officer; Director · 4 filings · Latest: Jun 11, 2026
INSMED Inc
Xilio Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
INSM | Bonstein Sara | — | Jan 7, 2025 | Proposed Sale | $66.11 | 3,470 | $229.4K | — |
← Previous
Page 2 of 2